CAH logo

CARDINAL HEALTH INC

CAHNYSE
πŸ† #292 by market capEarnings Oct 29US Equity
$221.12β–² $0.82 (+0.37%)
Live
πŸ””
Track CAH
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 0.4%
7dβ–Ό 0.3%
14dβ–Ό 4.9%
30dβ–Ό 5.7%
ytdβ–² 7.6%
1yβ–² 43.1%
🏦Market Cap
$51.79B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
+14.2%
Healthy
πŸ“ŠGross Margin
3.8%
Thin
πŸ’΅FCF Margin
1.8%
Thin
βš–οΈP/S Ratio
0.2x
Cheap
Otter Score
80
Good

Trading Snapshot

Day Range
$219.02 – $222.79
52-Week Range
$150.78 – $258.30
Volume
$2.42B
Avg Volume
$2.98B
Shares Outstanding
234.2M
Next Earnings
Nov 24, 2026

Fundamentals Snapshot

Annual Revenue
$254.25B
Last Q Revenue
$63.86B
P/E Ratio
30.4
P/S Ratio
0.2x
EPS (TTM)
$7.26
Dividend Yield
0.93%
Dilution (1yr)
+0.0%

Why Investors Own CAH

  • βœ“High-growth profile β€” revenue up -1.0% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 77% gross margin and 21% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

CAH logo

CARDINAL HEALTH INC

CAH
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$254.2Bβ–² +14.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
3.8%β–² +4.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$2.6Bβ–² +14.9% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$4.5Bβ–² +144.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
237.0Mβ–² +0.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$5.1Bβ–² +$1.2B YoY
StockOtter Β· stockotter.space

About CARDINAL HEALTH INC

Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Good
80/100

Analyst Ratings

β“˜
Consensus
Buy
24 analysts
Strong Buy8
Buy13
Hold3
Sell0
Strong Sell0
Ratings as of Sep 2026

Latest News & Updates